ACADIA PHARMACEUTICALS INC — Director's Dealing 2013

Dec 16, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2013-12-12

Reporting Person: Aasen Thomas H (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-12-02	Common Stock	G	2000	—	Disposed	27348	Direct
2013-12-12	Common Stock	M	11000	$1.55	Acquired	38348	Direct
2013-12-12	Common Stock	M	1000	$6.95	Acquired	39348	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-12-12	Stock Option (right to buy)	$1.55	M	11000	Disposed	2020-03-11	Common Stock (11000)	Direct
2013-12-12	Stock Option (right to buy)	$6.95	M	1000	Disposed	2015-03-10	Common Stock (1000)	Direct

Footnotes

F1: This disposition reflects a charitable gift made by the reporting person.

F2: Includes 5,263 shares acquired on November 29, 2013 by Mr. Aasen under the ACADIA Pharmaceuticals Employee Stock Purchase Plan.

F3: 25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.

F4: 25% of the shares subject to the Stock Option vested and became exercisable on March 11, 2006. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.